Stay updated with breaking news from Brain Modulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medtronic, a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its Percept™ RC Deep Brain Stimulation (DBS) system.
Rechargeable neurostimulator joins the Medtronic Percept™ family – the first and only deep brain stimulation system with sensing, directionality, and advanced programming. DUBLIN, Jan. 8, 2024...
Medtronic won FDA approval of its Percept RC deep brain stimulation system, the latest member of its Percept line of DBS devices.
/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its...
Medtronic announced that it received CE mark approval for its Percept RC neurostimulation device.